Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy

Clarice S. Groeneveld, Jacqueline Fontugne, Luc Cabel, Isabelle Bernard‐Pierrot, François Radvanyi, Yves Allory, Aurélien de Reyniès

European Journal of Cancer · 2021 · 153 citations · 24 references

Concepts

References

24